As of mid-October 2022, StrokeDx Inc. completed a series seed with FreeFlow Ventures as the lead. StrokeDx is currently operated by co-founders Alexander Ballatori and Shane Shahrestani.
This round, which was composed of additional investments from the California Institute of Technology and several HealthTech angel investors, marks a significant milestone in developing portable, rapid, noninvasive stroke diagnostic technologies.